Aclaris Therapeutics, Inc. (ACRS)
3.65
-0.04
(-1.08%)
USD |
NASDAQ |
Feb 10, 16:00
3.64
-0.01
(-0.27%)
After-Hours: 20:00
Aclaris Therapeutics Total Assets (Quarterly) : 175.53M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 220.49M |
| PMV Pharmaceuticals, Inc. | 133.84M |
| Atea Pharmaceuticals, Inc. | 342.96M |
| Instil Bio, Inc. | 211.77M |
| Puma Biotechnology, Inc. | 202.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 55.43M |
| Shareholders Equity (Quarterly) | 120.10M |
| Debt to Equity Ratio | 0.0187 |
| Current Ratio | 3.925 |
| Net Debt Paydown Yield | 0.06% |